If undiagnosed or poorly managed, CD can escalate in a subset of patients, leading to the development of citrullinemia type II (CTLN2) (OMIM #603471) [27, 41], recently renamed as adolescent and adult CD (AACD; [34]). This evidence concerns the gene SLC25A13 and Cowden disease.